Results 121 to 130 of about 76,116 (300)

Hospital Volume and Operative Mortality in Pancreaticoduodenectomy and Hepatectomy: Analysis of the National Clinical Database in Japan

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background/Purpose This study evaluated the association between institutional advanced hepatobiliary‐pancreatic (HBP) surgical volume and operative mortality for pancreaticoduodenectomy (PD) and advanced hepatectomy using data from the Japanese National Clinical Database.
Yoshitaro Shindo, Hideki Endo, Hiroyuki Yamamoto, Hidenori Takahashi, Shigeru Marubashi, Atsushi Nanashima, Itaru Endo, Hideki Ueno, Ken Shirabe, Masafumi Nakamura, Hiroaki Nagano, Masayuki Ohtsuka   +11 more
wiley   +1 more source

Cholangiocarcinoma: a guide for the nonspecialist

, 2018
Munirah Alsaleh,1 Zoe Leftley,1 Thomas A Barbera,1 Paiboon Sithithaworn,2 Narong Khuntikeo,2 Watcharin Loilome,2 Puangrat Yongvanit,2 I Jane Cox,3 Nittaya Chamodol,2 Richard RA Syms,4 Ross H Andrews,1,2 Simon D Taylor-Robinson1 1Division of Surgery and ...
Alsaleh M, Yongvanit P, Cox IJ, Taylor-Robinson SD, Leftley Z, Loilome W, Andrews RH, Syms RRA, Khuntikeo N, Barbera TA, Sithithaworn P, Chamodol N   +11 more
core  

The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Cholangiolocarcinoma (CLC) is a rare liver cancer with ≥ 80% ductular configuration (DC). Given its rarity, its clinicopathological characteristics remain poorly understood, and its status as a distinct disease entity remains controversial.
Takamichi Ishii, Kenta Makino, Etsuro Hatano, Mina Komuta, Jun Akiba, Yoshihiro Sakamoto, Shun‐Ichi Ariizumi, Goro Honda, Toru Hisaka, Yutaka Takeda, Akira Shimizu, Kentaro Yasuchika, Takashi Mizuno, Daisuke Asano, Atsushi Fujio, Naoto Gotohda, Chie Kitami, Koji Amaya, Hiroshi Sadamori, Manabu Kawai, Akiyoshi Nakakura, Masafumi Nakamura, Itaru Endo   +22 more
wiley   +1 more source

Leptin enhances cholangiocarcinoma cell growth

, 2008
Cholangiocarcinoma is a strongly aggressive malignancy with a very poor prognosis. Effective therapeutic strategies are lacking because molecular mechanisms regulating cholangiocarcinoma cell growth are unknown.
De Morrow S., Glaser S., C. Rychlicki, G. Svegliati Baroni, G. Fava, Marucci L., A. Di Sario, Francis H., Alvaro D., Alpini G., BENEDETTI, Antonio, A. Benedetti, L. Trozzi, SVEGLIATI BARONI, Gianluca, D. Alvaro, S. Glaser, FAVA, GABRIELE, C. Candelaresi, I. Bearzi, Bearzi I., G. Svegliati-Baroni, S. Demorrow, M. Marzioni, MARZIONI, MARCO, S. Saccomanno, ALVARO, Domenico, G. Alpini, Di Sario A., TROZZI, Luciano, Venter J., L. Marucci, J. Venter, Rychlicki C., SACCOMANNO, STEFANIA, Candelaresi C., H. Francis   +35 more
core   +1 more source

Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus‐Based Conceptual Framework

Journal of Surgical Oncology, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis despite surgical resection, yet the prognostic literature remains fragmented across hundreds of single‐institution studies that vary in design, covariates, and analytical approaches.
Muhammad Maisam Ali, Kaleem S. Ahmed, Clayton T. Marcinak, Syed Ali Tayyeb Hasan, Anne D. Letocha, Noorain Ahmad, Haider bin Khalid, Kainat Fatima, Syed Nabeel Zafar   +8 more
wiley   +1 more source

Recent advances in pharmacotherapy of cholangiocarcinoma

Cholangiocarcinoma (CCA) is a highly aggressive cancer with poor prognosis and limited treatments. This thesis reviews recent advances in pharmacotherapy, focusing on targeted therapies, immunotherapies, and emerging combinations.
Lin, Yo-Yen
core  

Clinical Aspect of Peripheral Cholangiocarcinoma: A Study of 7 Hepatectomy Cases [PDF]

, 1993
To clarify the features and problems presented by a peripheral cholangiocarcinoma (CCC), seven patients with hepatectomy from the First Department of Surgery, Nagasaki University School of Medicine (6 patients), and from Department of Surgery, National ...
Nanashima, Atsushi, Terada, Ryusuke, Miura, Toshi, Tomita, Masao, Yoshida, Ryuichiro, Hayashida, Ken, Uchikawa, Tetsuya, Kusano, Hiroyuki, Nishikawa, Kiyoomi, Sasaki, Nobufumi, Nakagoe, Tohru, Shimoyama, Takatoshi, Shimizu, Teruhisa, Kida, Harumi, Azuma, Kohji, Shinkai, Kiyoto   +15 more
core  

Outcomes Following Total Pancreatectomy With and Without Vascular Resection: A NSQIP Analysis Comparing Trends in Patient Selection and Outcomes Over 5 Years

Journal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Advances in neoadjuvant therapy and surgical techniques have led to more total pancreatectomies (TP) with vascular resection for pancreatic cancer. This study assesses contemporary outcomes of TP with venous (VR) and arterial (AR) resections compared to non‐vascular resection (NVR).
Zofia Czarnecka, Kevin Verhoeff, A. M. James Shapiro, Chaya Shwaartz   +3 more
wiley   +1 more source

Pathology of Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma [PDF]

Clinical Liver Disease, 2021
openaire   +2 more sources

Construction of a Non‐Invasive Predictive Model Based on PIVKA‐II Combined With MRI Imaging Features for Evaluating Microvascular Invasion in Hepatocellular Carcinoma

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study developed a non‐invasive model using PIVKA‐II and MRI features to predict microvascular invasion in hepatocellular carcinoma, providing a reliable tool for early risk assessment and personalized treatment planning. The study included 98 patients with pathologically confirmed HCC (Child‐Pugh A, BCLC stage A), comprising 43 MVI ...
Di Gao, Rui‐Qi Jin, Hong‐Wei Wang
wiley   +1 more source